海洋微生物的抗炎化合物的最新进展
Guihua Yang1, Miaoping Lin1, Kumaravel Kaliaperumal2
1Guangxi Key Laboratory of Marine Drugs, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Marine drugs
|September 27, 2024
概括
海洋微生物产生有希望的抗炎化合物. 本次审查强调了来自海洋真菌的252种代谢物,重点关注它们的结构和开发新抗炎药物的潜力.
科学领域:
- 海洋微生物学 海洋微生物学
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 海洋微生物是各种二次代谢物的丰富来源.
- 这些代谢物中的许多都表现出显著的生物活性,包括抗炎性质.
- 识别新型抗炎药物对于开发新的治疗策略至关重要.
研究的目的:
- 审查和总结来自海洋微生物的抗炎天然产品.
- 详细说明这些化合物的来源,化学结构和药理性质.
- 突出海洋微生物代谢物的潜力,作为抗炎药物开发的化合物.
主要方法:
- 2021-2023年科学出版物的文献综述.
- 系统地收集和分析有关具有抗炎活性的海洋微生物二次代谢物的数据.
- 根据化合物的化学结构和来源对化合物进行分类.
主要成果:
- 大约有252种抗炎化合物被确定,其中129种是新发现.
- 海洋真菌是这些化合物的主要来源.
- 识别的化合物在结构上被分为多基基 (51.2%),基 (21.0%),基 (18.7%),胺或 (4.8%),类固醇 (4.3%).
结论:
- 海洋微生物的二次代谢物是发现新型抗炎化合物的宝贵资源.
- 这些化合物的结构多样性为药物化学优化提供了机会.
- 对这些代谢物的进一步研究可能会为人类健康带来有前途的临床应用.
更多相关视频
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
129
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
129
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Bioremediation
18.2K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
Antimicrobial Proteins
947
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
947
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145


